Anebulo Pharmaceuticals, Inc. (ANEB)
0.3574
-0.03
(-8.36%)
USD |
OTCM |
Sep 09, 16:00
Anebulo Pharmaceuticals EPS Diluted (Quarterly) : -0.0487 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.0487 |
| September 30, 2025 | -0.0525 |
| June 30, 2025 | -0.0522 |
| March 31, 2025 | -0.0408 |
| December 31, 2024 | -0.0898 |
| September 30, 2024 | -0.0849 |
| June 30, 2024 | -0.0521 |
| March 31, 2024 | -0.0638 |
| December 31, 2023 | -0.1054 |
| September 30, 2023 | -0.0968 |
| June 30, 2023 | -0.0974 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.1092 |
| December 31, 2022 | -0.1493 |
| September 30, 2022 | -0.1115 |
| June 30, 2022 | -0.0995 |
| March 31, 2022 | -0.0804 |
| December 31, 2021 | -0.046 |
| September 30, 2021 | -0.0665 |
| June 30, 2021 | -1.247 |
| March 31, 2021 | -0.3754 |
| June 30, 2020 | -0.0074 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.999M |
| Total Expenses (Quarterly) | 1.999M |
| Enterprise Value | 5.642M |
| Earnings Yield | -54.34% |
| Normalized Earnings Yield | -54.34 |